Journal of Clinical Virology

Papers
(The TQCC of Journal of Clinical Virology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Trends in the detection of viruses causing gastroenteritis over a 10-year period and impact of nonpharmaceutical interventions98
Corrigendum to “Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus” Journal of Clinical Virology 45 (57
Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in 57
Corrigendum to “First international proficiency study on human papillomavirus testing in cervical cancer screening” [J Clin Virol. 2023 Oct;167:105581]56
Editorial Board56
Comparison of sputum specimens and nasopharyngeal swab specimens for diagnosis of acute human metapneumovirus-related lower respiratory tract infections in adults54
ESCV/PASCV Membership51
“The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain”50
Persistence of G10P[11] neonatal rotavirus infections in southern India49
Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain44
Comparison of two assays to diagnose herpes simplex virus in patients with central nervous system infections43
Enrichment of SARS-CoV-2 sequence from nasopharyngeal swabs whilst identifying the nasal microbiome42
Dried blood spot sampling for hepatitis C virus infection: A new tool to simplify testing algorithms39
Quantification of human immunodeficiency virus type 2 (HIV-2) viral load in plasma: Comparison of three commercial assays38
The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays38
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens37
Subclinical CMV viremia is associated with increased nosocomial infections and prolonged hospitalization in patients with systemic autoimmune diseases37
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization37
Multicenter performance evaluation of the Elecsys HCV Duo immunoassay37
Epidemiology of hand, foot and mouth disease and genomic surveillance of coxsackievirus A10 circulating in Zhejiang Province, China during 2017 to 202235
Evaluation of a next generation sequencing assay for Hepatitis B antiviral drug resistance on the oxford nanopore system33
Performance evaluation of the Abbott Alinity Hepatitis C antigen next assay in a US urban emergency department population32
Development of real-time RT-PCR assays to detect measles virus on the Hologic Panther Fusion® System30
What Every Clinical Virologist Should Know About The VALID Act On Behalf of the Pan-American Society for Clinical Virology Clinical Practice Com30
Recent HIV-1 infection in Israel 2017–2021: Evaluation of geenius and HIV-1/2 combo assays for identifying recent infection detected by Sedia assay and assessment of factors related to recent infectio29
Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.29
Editorial Board29
Editorial Board29
Performance of the Xpert™ Mpox PCR assay with oropharyngeal, anorectal, and cutaneous lesion swab specimens29
A multi-center study to determine genetic variations in the fusion gene of respiratory syncytial virus (RSV) from children <2 years of age in the U.S.28
Retrospective identification of congenital cytomegalovirus infection using dried blood samples - missed opportunities and lessons28
Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.28
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.727
Multicenter benchmarking of short and long read wet lab protocols for clinical viral metagenomics26
The association of Torque Teno viral load with CMV and BKV infection in pediatric and adolescent kidney transplant patients.26
Clinical presentation, viral shedding, and neutralizing antibody responses of mpox cases in South Korea: Single center experience25
Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use25
Highly sensitive and specific detection of the SARS-CoV-2 Delta variant by double-mismatch allele-specific real time reverse transcription PCR24
Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use24
Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)—A prospective multicenter study24
Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study23
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations23
Human coronaviruses: Origin, host and receptor23
Application of the ViroKey® SQ FLEX assay for detection of cytomegalovirus antiviral resistance22
Reconfirming HIV serostatus in three West African Military ART clinics22
Predictors of chronic joint pain after Chikungunya virus infection in the INOVACHIK prospective cohort study21
Torque-Teno virus to optimize timing of vaccination against severe acute respiratory syndrome coronavirus 2 in solid organ transplant recipients21
Optimising nucleic acid recovery from rapid antigen tests for whole genome sequencing of respiratory viruses20
Direct whole-genome sequencing of HIV-1 for clinical drug-resistance analysis and public health surveillance20
Non-polio enterovirus aseptic meningitis in infants up to three months of age, the bacterial mask of viral disease: A retrospective cohort study20
ESCV/PASCV Membership19
Comparison of humoral immunogenicity in solid organ transplant recipients after third-dose mRNA vaccine with homologous or heterologous schedules: An observational study19
Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection19
Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test19
Unusual high number of spike protein mutations for the SARS-CoV-2 strains detected in Hong Kong18
Editorial Board18
Opt-out HIV screening in adults attending the Emergency Department of a London teaching hospital18
Comparison of analytical sensitivity of the eight rapid antigen detection kits for detecting SARS-CoV-2 virus18
Human pegivirus 1 infection in lung transplant recipients: Prevalence, clinical relevance and kinetics of viral replication under immunosuppressive therapy18
Influence of preanalytical parameters on influenza and respiratory syncytial virus molecular detection18
The molecular epidemiology of respiratory syncytial virus in Ontario, Canada from 2022–2024 using a custom whole genome sequencing assay and analytics package18
Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome18
ESCV/PASCV Membership18
ESCV/PASCV Membership18
Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study17
Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants17
Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures16
A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the field16
Investigation of suspected false positive norovirus results on a syndromic gastrointestinal multiplex molecular panel16
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis16
Comparison of nucleocapsid antigen with strand-specific reverse-transcription PCR for monitoring SARS-CoV-2 infection16
Prevalence and persistence of HPV-16 molecular variants in the anal canal of men: The HIM study16
Current regulatory landscape for viral point-of-care testing in the United States16
Clinical utility of SARS-CoV-2 subgenomic RT-PCR in a pediatric quaternary care setting16
Circulating serotypes and genotypes of dengue virus during the 2023 outbreak in Eastern Nepal15
Editorial Board15
Characteristics of hepatitis E viral infections in Hungary15
Detection of intrathecal antibodies to diagnose enterovirus infections of the central nervous system15
Detection of early phase human T-cell leukemia virus type 1 and 2 infection with an improved confirmatory test15
Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response15
Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities15
Editorial Board15
DENV-1 genotype V linked to the 2022 dengue epidemic in Southern Brazil15
Childhood encephalitis hospitalizations associated with virus agents in medium-endemic states in India14
In vitro fitness of SARS-CoV-2 variants as assessed by competition experiments followed by ddRT-PCR and whole genome sequencing14
Evaluation of four laboratory-based high-throughput SARS-CoV-2 automated antigen tests compared to RT-PCR on nasal and oropharyngeal samples14
A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses14
Parvovirus B19 remains an underestimated pathogen among infections during gestation in Argentina: Insights through the study of symptomatic and asymptomatic pregnant patients and newborns from Córdoba14
Reduced sensitivity of SARS-CoV-2 PCR testing with single-nostril nasal swabs14
Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment14
The Evolving Landscape of Norovirus GII Genotypes in Asia: A Systematic Review and Meta-Analysis14
Clinical features and outcomes of neonatal COVID-19: A systematic review14
HIV-1 genotypic resistance testing using single molecule real-time sequencing14
Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects14
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings13
The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis13
Arbovirus outbreak in a rural region of the Brazilian Amazon13
ESCV/PASCV Membership13
Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals13
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients13
Editorial Board13
Genotypic testing improves detection of antiviral resistance in human herpes simplex virus13
Clinical characterization of COVID-19 breakthrough infections, Philippines13
Comparison of the Ct-values for genomic and subgenomic SARS-CoV-2 RNA reveals limited predictive value for the presence of replication competent virus13
Prevalence of hepatitis delta virus among chronic hepatitis B carriers in a large tertiary center in the Netherlands13
Comparison of two new HTLV-I/II screening methods, Abbott Alinity i rHTLV-I/II and Diasorin LIAISON® XL murex recHTLV-I/II, to Abbott architect rHTLVI/II assay12
Clinical scoring system to predict viable viral shedding in patients with COVID-1912
Evaluation of a high volume antigen test for detection of SARS-CoV-212
Diagnosing congenital cytomegalovirus infections using archived dried blood spots: A 15-year observational study, Portugal12
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues12
COVID-19 patient characteristics and time to viral clearance: A retrospective observational study in a multiethnic population (United Arab Emirates)12
A Prospective Study of Plasma and Bronchoalveolar Lavage Fluid CMV DNA Load Quantification for the Diagnosis and Outcome of CMV Pneumonitis in Immunocompromised Hosts12
Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series12
The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing12
High proportion of norovirus infection and predominance of GII.3 [P12] genotype among the children younger than 5 in Sabah, Malaysian Borneo12
Classification of HIV-1 virological treatment failure using the Roche cobas plasma separation card on cobas 8800 compared to dried blood spots on Abbott RealTime HIV-112
Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study)12
Genotypic shift in rotavirus associated with neonatal outbreaks in Seoul, Korea12
TRANSLACOL project: Nodal human papillomavirus tumoral DNA detection by ddPCR for survival prediction in early cervical cancer patients without pelvic lymph node invasion11
Editorial Board11
Detection of SARS-CoV2 variants by Mesa Accula11
Screening for cytomegalovirus shedding in vagina and saliva: Significant differences between biological fluids, swab types and storage durations in DNA recovery11
Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-1911
Evaluation of the Geenius HIV 1/2 confirmatory assay for HIV-2 samples isolated in Japan11
Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves11
Arbovirus surveillance in pregnant women in north-central Nigeria, 2019–202210
Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays10
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study10
Epidemiological and molecular characteristics of a measles outbreak in northern Vietnam, 2013–201410
HUMAN COSAVIRUS INFECTION IN HIV SUBJECTS WITH DIARRHOEA: PERSISTENT DETECTION ASSOCIATED WITH FATAL OUTCOME10
Molecular epidemiology of a Parainfluenza Type 3 virus outbreak: Informing infection control measures on adult hematology wards10
2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)10
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses10
A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-1910
Impact of metformin on HBV replication: No evidence of suppression in vitro10
Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan10
Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study10
Viral metagenomic sequencing in a cohort of international travellers returning with febrile illness10
Coinfections and iterative detection of respiratory viruses among 17,689 patients between March 2021 and December 2022 in Southern France10
SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests10
Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants10
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study10
0.1532199382782